Influence of apoptosis (BCL2, FAS), cell cycle (CCND1) and growth factor (EGF, EGFR) genetic polymorphisms on survival outcome: An exploratory study in squamous cell esophageal cancer

Cancer Biology and Therapy

Volumn 6, Issue 10, 2007, Pages 1553-1558

  Jain, Meenu ^a   Kumar, Shaleen ^a   Upadhyay, Rohit ^a   Lal, Puneeta ^a   Tiwari, Anu ^a   Ghoshal, Uday C ^a   Mittal, Balraj ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Apoptosis; Polymorphisms; Survival

Indexed keywords

CELL CYCLE PROTEIN; CELL CYCLE PROTEIN CCND1; CISPLATIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FAS ANTIGEN; PROTEIN BCL 2; CYCLIN D1;

ADULT; AGED; APOPTOSIS; ARTICLE; BCL2 GENE; CANCER LOCALIZATION; CANCER SURVIVAL; CCND1 GENE; CELL CYCLE; EGF GENE; EGFR GENE; ESOPHAGUS CANCER; FAS GENE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POLYMERASE CHAIN REACTION; RADIATION DOSE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; ESOPHAGUS TUMOR; GENETICS; MIDDLE AGED; MORTALITY; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD95; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CYCLIN D1; EPIDERMAL GROWTH FACTOR; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, EPIDERMAL GROWTH FACTOR; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 41649099772     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.6.10.4709     Document Type: Article

References (28)